Shigella Infection Clinical Trial
Official title:
A Comparative Double Blind Placebo-Controlled Study of Immunogenicity and Safety of Two Doses 10^5 and 10^7 CFU of SC599 Oral Vaccine, a Live Attenuated Shigella Dysenteriae 1 Vaccine Strain in Healthy Human Adult Volunteers
The purpose of this study is to assess the immune response produced by two doses of SC599 vaccine compared to placebo.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04634513 -
Shigella CVD 31000: Study of Responses With Shigella-ETEC Vaccine Strain CVD 1208S-122
|
Phase 1 | |
Active, not recruiting |
NCT04242264 -
Phase 2 Shigella Vaccine and Challenge
|
Phase 2 | |
Completed |
NCT01336699 -
Safety and Immunogenicity of Two Live, Attenuated Oral Shigella Sonnei Vaccines: WRSs2 and WRSs3
|
Phase 1 | |
Recruiting |
NCT04694235 -
Egg Intervention During Pregnancy in Indonesia
|
N/A |